Efficacy and safety of supaglutide monotherapy in patients with type 2 diabetes

被引：0
|
作者：
Wang, Q. [1 ]
Zhou, Y. [2 ]
Li, L. [1 ]
Wang, W. [3 ]
Tong, G. [3 ]
Shi, B. [4 ]
Hu, X. [5 ]
Bian, F. [6 ]
Li, Q. [7 ]
Wang, Y. [8 ]
Zhao, N. [9 ]
Ma, J. [10 ]
Li, Y. [2 ]
Zhu, D. [3 ]
机构：
[1] Shanghai Innogen Biomed Engn Co Ltd, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Sch, Huashan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China
[3] Nanjing Univ, Dept Endocrinol, Drum Tower Hosp, Med Sch, Nanjing, Peoples R China
[4] Soochow Univ, Dept Endocrinol & Metab, Affiliated Hosp 1, Suzhou, Peoples R China
[5] Shandong Univ, Dept Endocrinol & Metab, Jinan Cent Hosp, Jinan, Peoples R China
[6] Cangzhou Peoples Hosp, Dept Endocrinol, Cangzhou, Peoples R China
[7] Zhengzhou Univ, Dept Endocrinol, Affiliated Hosp 2, Zhengzhou, Peoples R China
[8] Nan Yang First Peoples Hosp, Nanyang, Peoples R China
[9] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China
[10] Nanjing First Hosp, Dept Endocrinol, Nanjing, Peoples R China
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
640
引用
收藏
页码：S322 / S323
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Supaglutide Monotherapy in Patients with Type 2 Diabetes
    Wang, Qinghua
    Zhou, Yue
    Wang, Weimin
    Tong, Guoyu
    Jia, Weina
    Li, Liang
    Cheng, Zhifeng
    Lu, Yibing
    Shi, Bimin
    Bian, Fang
    Wang, Yihua
    Shi, Xiaoxia
    Li, Qingju
    Su, Xiuhai
    Wang, Kun
    Yuan, Guoyue
    Li, Liping
    Ling, Hongwei
    Hu, Xiaolin
    Wang, Yangang
    Zhao, Naiqing
    Yang, Yehong
    Ma, Jianhua
    Li, Yiming
    Zhu, Dalong
    DIABETES, 2023, 72
  • [2] Efficacy and safety of supaglutide as add-on to metformin in patients with type 2 diabetes
    Anwar, D.
    Bao, Y.
    Zhou, Y.
    Chen, S.
    Zhou, J.
    Li, L.
    Cheng, Z.
    Dong, X.
    Shi, X.
    Zhao, N.
    Yang, Y.
    Ma, J.
    Li, Y.
    Wang, Q.
    Jia, W.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S322 - S322
  • [3] Efficacy and Safety of Supaglutide as Add-on to Metformin in Patients with Type 2 Diabetes
    Anwar, Dilbar
    Bao, Yuqian
    Zhou, Yue
    Chen, Si
    Zhou, Jian
    Li, Liang
    Cheng, Zhifeng
    Dong, Xiaolin
    Shi, Xiaoxia
    Su, Xiuhai
    Li, Liping
    Wang, Haifang
    Wang, Yihua
    Li, Shu
    Li, Qingju
    Li, Xing
    Liu, Ming
    Sun, Jiao
    Zhao, Naiqing
    Yang, Yehong
    Ma, Jianhua
    Li, Yiming
    Wang, Qinghua
    Jia, Weiping
    DIABETES, 2023, 72
  • [4] Efficacy and safety of evoglipitin monotherapy in patients with type 2 diabetes
    Kim, D.
    Park, J.
    Park, S.
    Lee, M.
    Yoon, K.
    DIABETOLOGIA, 2016, 59 : S357 - S358
  • [5] Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes
    Nonaka, Kenji
    Kakikawa, Taro
    Sato, Asako
    Okuyama, Kotoba
    Fujimoto, Go
    Kato, Naoki
    Suzuki, Hideyo
    Hirayama, Yukio
    Ahmed, Tuli
    Davies, Michael J.
    Stein, Peter P.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (02) : 291 - 298
  • [6] A Pooled Analysis of the Efficacy and Safety of Saxagliptin as Monotherapy in Patients with Type 2 Diabetes
    Hirshberg, Boaz
    Bryzinski, Brian
    Xu, John
    Iqbal, Nayyar
    JOURNAL OF DIABETES & METABOLISM, 2015, 6 (04)
  • [7] Efficacy and Safety of Dapagliflozin as Monotherapy for Type 2 Diabetes Mellitus in Japanese Patients
    Kaku, Kohei
    Inoue, Satoshi
    Matsuoka, Osamu
    Kiyosue, Arihiro
    Azuma, Haruna
    Hayashi, Nobuya
    Tokudome, Takuto
    Langkilde, Anna Maria
    Parikh, Shamik
    DIABETES, 2012, 61 : A260 - A260
  • [8] Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes
    Aschner, P.
    Katzeff, H. L.
    Guo, H.
    Sunga, S.
    Williams-Herman, D.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2010, 12 (03): : 252 - 261
  • [9] Efficacy and Safety of Saxagliptin as Monotherapy in Patients with Type 2 Diabetes: A Pooled Analysis
    Hirshberg, Boaz
    Bryzinski, Brian
    Xu, John
    Monyak, John
    Iqbal, Nayyar
    DIABETES, 2014, 63 : A610 - A610
  • [10] Efficacy and Safety of Rivoglitazone as Monotherapy for Type 2 Diabetes Mellitus
    Chou, Hubert S.
    Moberly, James
    Mun, Yong
    Choi, Youngsook
    Merante, Domenico
    Truitt, Kenneth E.
    DIABETES, 2010, 59 : A183 - A183
12345